Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Staging PET/CT Better Defines Extent of Mantle Cell Lymphoma

Key clinical point: 18F-fluorodeoxyglucose PET/CT helps stage mantle cell lymphoma, sometimes altering management.

Major finding: Compared with CT alone, PET/CT led to upstaging in 17% of patients and down-staging in 2% of patients.

Study details: A two-center retrospective cohort study of 122 patients with mantle cell lymphoma.

Disclosures: No outside funding was disclosed. Dr. Albano reported having no relevant conflicts of interest.